Ventura BioMed Investors
Overview
A privately held investment group and venture capital firm focused on early-stage life science companies. The firm prefers to invest in the healthcare sector.
Portfolio Companies
8
Website
ventura-biomed.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NEOsphere Biotechnologies GmbH | Jul 2022 | Series A | Lead |
| Abalos Therapeutics | Oct 2021 | Series A Extension | Co-investor |
| Navignostics AG | Nov 2022 | Seed | Co-investor |
| Nia Health | May 2023 | Seed | Co-investor |
| Qanatpharma | Jul 2023 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ventura BioMed Investors based?
Ventura BioMed Investors is headquartered in Zug, Zug, Switzerland.
When was Ventura BioMed Investors founded?
Founding year information for Ventura BioMed Investors is not publicly available.
How many portfolio companies does Ventura BioMed Investors have?
Ventura BioMed Investors has 8 portfolio companies in Caplight's dataset.
What are some companies in Ventura BioMed Investors's portfolio?
Portfolio companies visible on Caplight include NEOsphere Biotechnologies GmbH, Abalos Therapeutics, Navignostics AG, Nia Health, Qanatpharma.
What was Ventura BioMed Investors's most recent investment shown here?
Ventura BioMed Investors's most recent investment in this portfolio sample was in Qanatpharma in 2023.
What sectors does Ventura BioMed Investors focus on?
Ventura BioMed Investors focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does Ventura BioMed Investors focus on?
Ventura BioMed Investors typically invests at the Early stage.